The global wound care market was valued at USD 19,657.8 million in 2018. Increase in prevalence of chronic disorders such as diabetes and obesity, rising elderly population coupled with increase in traumatic injuries and surging volume of surgeries performed across the globe are key factors driving the global wound care market.
Increase in incidence of chronic wounds in developed regions is expected to drive the demand for advanced wound care products. For instance, according to the National Institutes of Health, chronic wounds affect 6.5 million individuals in the U.S. annually. Rapid rise in prevalence of chronic disorders such as diabetes and obesity are major factors for the formation of chronic wounds. Chronic wounds including diabetic foot ulcers, pressure ulcers, and venous leg ulcers are difficult and expensive to heal posing huge cost burden on the healthcare systems. For instance, the cost of chronic wounds in the U.S. is estimated at USD 25 billion per year. These factors are anticipated to fuel the demand for advanced wound care products over the forecast timeframe.
The global Wound Care market is expected to develop 29.6 by 2030, at a compound annual increase in price (CAGR) of 4.1% throughout the forecast period.
Moreover, rapid rise in traumatic injuries and road accidents and increase in surgeries performed across the globe are expected to drive the demand for wound care products in the future. However, high cost of advanced wound care products and risk associated with wound care products is expected to hinder the growth of the market over the forecast period.
The global wound care market is categorized based on product, wound type, end-users, and region. On the basis of product, advanced wound care segment held the largest share of the global wound care market in 2018 owing to wide adoption of silicone dressings for healing chronic wounds. By wound type, chronic wounds segment is anticipated to grow at a lucrative rate over the forecast period. Geographically, North America dominated the global wound care market in 2018, however, Asia Pacific is expected to be the fastest growing region by 2025.
Key players operating in the global wound care market include Mölnlycke Health Care AB, 3M, Coloplast, Smith & Nephew plc, ConvaTec Group plc, Ethicon Inc. (Johnson & Johnson), Medtronic plc, Derma Sciences Inc. (Integra LifeSciences Corporation), Medline Industries, Inc., and Baxter International Inc. among others.
Wound Care Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2030||USD 29.6 billion|
|Growth Rate||CAGR of4.1% during 2022-2030|
|Segment Covered||Product, application, end use|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and Africa|
|Key Players Profiled||Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp., Medtronic, 3M, Derma Sciences Inc. (Integra LifeSciences)|
Key Segment Of The Wound Care Market
Product, 2022-2030 (USD Million)
o Advanced Wound Dressing
• Foam Dressings
• Hydrocolloid Dressings
• Film Dressings
• Alginate Dressings
• Hydrogel Dressings
• Collagen Dressings
• Other Advanced Dressings
o Surgical Wound Care
• Sutures & staples
• Tissue adhesive and sealants
• Anti-infective dressing
o Traditional Wound Care
• Medical tapes
• Cleansing agents
o Wound Therapy Devices
• Negative pressure wound therapy
• Oxygen and hyperbaric oxygen equipment
• Electric stimulation devices
• Pressure relief devices
Application, 2022-2030 (USD Million)
o Chronic Wounds
• Diabetic foot ulcers
• Pressure ulcers
• Venous leg ulcers
• Other chronic wounds
o Acute Wounds
• Surgical & traumatic wounds
End-use, 2022-2030 (USD Million)
• Specialty Clinics
• Home Healthcare
Regional Overview, 2022-2030 (USD Million)
• Rest of Europe
• Rest of Asia Pacific
• Rest of South America
Middle East and South Africa
The need for rapid wound-healing has significantly increased owing to the increasing number of patients suffering from diabetes and obesity. According to International Diabetes Federation (IDF), 463 million people were living with diabetes globally in 2019 and this number is expected to reach 700 million by 2045. These conditions have contributed to a surge in the number of patients with chronic wounds globally. Chronic wounds such as diabetic foot ulcers, venous leg ulcers and pressure ulcers pose huge healthcare burden. Diabetic foot ulcers are one of the major complications associated with diabetes with a global incidence rate of 6.3%. Rapid rise in prevalence of diabetes will increase the risk of chronic wounds. For instance, it is estimated that the lifetime risk of developing a foot ulcer in diabetic patient ranges from 19%-34%.
More than half of diabetic foot ulcers become infected and 20% results in amputation. Thus, increase in chronic wounds will propel demand for wound care products in the future. Rapid rise in chronic disorders will also lead to increased demand for surgical procedures. This, in turn, will elevate the number of surgical site infections post surgeries. Wound care products and therapy devices such as sutures, staplers, anti-infective dressings, and negative wound pressure therapy (NPWT) devices helps to treat large wounds caused post surgery, thereby reducing the risk of infections at the surgical site. Moreover, major industry players are also investing in R&D to develop technologically advanced wound care products. For instance, Coloplast announced the launch of Biatain Silicone foam dressing with unique 3DFit Technology and advanced five-layer construction used for the management of exuding wounds and the prevention of pressure injuries.
The global wound care market has been segmented based on product, wound type, end-users, and region. Based on product, the wound care market is segmented into advanced wound care products, surgical wound care products, and traditional wound care products. Advanced wound care products are further sub-categorized into advanced wound dressings, wound therapy devices, and wound care bioactives. Advanced wound dressings are further sub-classified into foam dressings, hydrocolloid dressings, antimicrobial dressings, film dressings, alginate dressings, hydrogel dressings, collagen dressings, and others. Wound therapy devices segment is further sub-categorized into negative pressure wound therapy (NPWT), oxygen and hyperbaric oxygen equipment, pressure relief devices, electric stimulation devices, and others. Wound care bioactives segment is sub-classified into biological skin substitutes, and topical agents. Surgical wound care products are categorized into staples & sutures, tissue adhesives, glues & sealants, and anti-infective dressings.
Traditional wound care products are further segmented into medical tapes, cleansing agents, and dressings. Advanced wound care segment held substantial share of the global market in 2018. Advanced wound dressing such as silicone foam dressing is majorly used for the treatment of non-healing chronic wounds. Advanced wound care products have anti-microbial properties that enable rapid healing of wounds and prevent infections.
On the basis on wound type, the global wound care market is categorized into chronic wounds and acute wounds. Chronic wounds are further sub-categorized into diabetic foot ulcers, venous leg ulcers, pressure ulcers, and others. Acute wounds are sub-classified into surgical and traumatic wounds, and burns. Acute wounds grabbed majority of the market share in 2018. However, chronic wounds are expected to witness a lucrative growth owing to surge in chronic diseases such as diabetes and obesity leading to formation of diabetic foot ulcers and pressure ulcers. Based on end-users, wound care market is segmented into hospitals and clinics, long-term care facilities, and home care settings. Hospitals & clinics dominated the global wound care market in 2018.
The global wound care market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global wound care market in 2018, however Asia Pacific is expected to grow at a highest pace through 2025.
Increase in incidence of diabetes and obesity along with surging volume of surgeries performed in the U.S. are major factors expected to drive the wound care market in the region. According to International Diabetes Federation (IDF), approximately 48 million individuals in North America were living with diabetes in 2019 and this is expected to reach 63 million by 2045, witnessing a rise of over 33% by 2045. Presence of such large patient population will increase the demand for wound care products in the future. Furthermore, increase in spending on wound care is other major factor likely to boost the growth of the market in North America.
However, Asia Pacific is expected to grow at a rapid pace over the next few years. There is a strong growth potential in the emerging economies such as India, and China. The rapidly rising geriatric population in countries such as India and China provide large market for wound care products. According to the United Nations, China and India together were home to over one third of the world’s population aged 60 years or over in 2017. Furthermore, according to International Diabetes Federation, there were 116.4 million people living with diabetes in China in 2019. Presence of high unmet medical needs along with surge in incidence of chronic ailments in the developing countries will fuel the need for wound care products over the coming years.